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Abstract 
Objectives: About 10–15% of women of childbearing age have endometriosis. The present study aimed to inves-
tigate the relationship between the severity of symptoms of endometriosis and the spread as well as the stage of 
the disease on ultrasonography. The present cross-sectional study evaluates the relationship between the severity of 
endometriosis symptoms and the spread of disease on ultrasonography in patients with endometriosis.
Results: Considering different analyses, the cumulative size of posterior deep infiltrative endometriosis (DIE) (less 
than 1 cm) is significantly correlated with minimal severity of dyspareunia and chronic pelvic pain. The incidence 
of dyspareunia was more prevalent in patients with complete stenosis of Douglas pouch than those with incom-
plete stenosis. Furthermore, the incidence of severe and very severe pain in patients with Douglas pouch stenosis 
is relatively higher than that in patients without stenosis. Only dyspareunia is related to the stage of endometriosis, 
and patients with dyspareunia are five times more at risk of a higher stage of the disease. The severity of dyspareunia 
is related to the stage of endometriosis and the severity of Douglas pouch stenosis. The results showed a correlation 
between chronic pelvic pain and r-ASRM score (revised American Society for Reproductive Medicine score).
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Introduction
Endometriosis refers to the extrauterine presence of 
endometrial glands and stroma leading to reactive 
inflammation and fibrosis [1].
Endometriosis affects 10–15% of women of child-
bearing age. Most of the patients are in the 18–25 age 
range [2]. The prevalence of the disease is even higher 
in symptomatic individuals (infertile individuals = 50%, 
patients with chronic pelvic pain = 50–90%) [3, 4]. Endo-
metriosis may cause severe painful symptoms such as 
dysmenorrhea, dyspareunia, and chronic pelvic pain 
while doing daily activities. The painful and chronic 
symptoms of this disease result in a poor quality of life 
in most of the patients [5–7]. The ovaries are one of the 
most common sites of endometriosis. Ovarian endome-
trioma is a pathognomonic manifestation of endometrio-
sis. Endometrioma is a type of cyst formed from bloody 
ectopic endometrial glands inside the ovary. This cyst has 
fibrous capsules and contains blood products [1].
Deep infiltrative endometriosis (DIE) is a specific form 
of endometriosis which refers to endometrial implants 
above 5  mm penetrating the peritoneal surface. These 
implants are highly active and almost associated with 
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for these implants include posterior areas, uterosacral 
ligament (USL), torus uterus (the retro-cervical part of 
uterine where uterosacral ligaments join there), poste-
rior wall of the vagina, and posterior wall of the rectum 
[8]. Although clinical findings may suggest the disease, 
imaging is needed for definitive diagnosis [4]. According 
to The American College of Obstetricians and Gynecolo-
gists (ACOG), transvaginal ultrasonography (TVS) is 
the first method found for studying endometriosis, and 
magnetic resonance imaging (MRI) is used if rectovagi-
nal or bladder involvement is suspected [1, 4]. The value 
of ultrasound in the diagnosis of endometriosis has been 
confirmed. Several papers have shown that TVS is com-
parable and even better than MRI [9]. TVS is highly spe-
cific for the detection of DIE in uterosacral ligaments, 
rectovaginal septum, vagina, and bladder [10]. The classic 
appearance of endometrioma in ultrasound examination 
is homogenous, and hypoechoic cystic ovarian lesion 
with low-level internal echo and without internal blood 
flow is displayed [1, 11] (Fig. 1a).
Accurate mapping of disease spread is critical for deter-
mining treatment strategy; however, the accuracy of TVS 
is confirmed. The dynamism of ultrasound increases its 
value and evaluates areas not examined by other imaging 
modalities.
Considering the importance of endometriosis and 
its relatively high prevalence among women as well as 
the wide range of endometriosis symptoms (including 
asymptomatic to severe life-threatening pain), research-
ers of this study sought to study the relationship between 
the various symptoms of the disease and the spread of 
its anatomical involvements. Moreover, accurate diag-
nosis of disease spread using non-invasive methods can 
be effective in the treatment and follow-up of patients. 
TVS is the most accessible imaging method as well as the 
selective modality for differentiating endometrioma from 
other cystic lesions. The present study seeks to identify 
cases of endometriosis which do not require invasive 
treatment or laparoscopic diagnosis. Furthermore, pre-
operative non-invasive mapping and grading of disease 




This cross-sectional study evaluates the relationship 
between the severity of endometriosis symptoms (dys-
pareunia, dysmenorrhea, and chronic pelvic pain) and 
the spread of disease on ultrasonography in patients 
with endometriosis. Target population included women 
with endometriosis symptoms (dyspareunia, dysmenor-
rhea, and chronic pelvic pain), referring to the radiology 
ward of Hazrat Rasool Akram Hospital in Tehran from 
2018 to 2020. All patients had a complete gynecologi-
cal examination by a gynecologist. None of the patients 
had a previous history of surgery due to endometriosis. 
Inclusion criterion included patients with endometriosis 
Fig. 1 a Typical ovarian endometrioma in a woman with 
long-standing chronic pelvic pain and dysmenorrhea (1, 2) gray-scale 
(1) and color Doppler (1) TVS images of right ovary demonstrate 
a unilocular cyst containing homogeneous low-level echoes and 
no internal vascularity at color Doppler US (classic appearance 
of an ovarian endometrioma). b USL DIE in a woman with severe 
pelvic pain and dyspareunia for 10 years with a history of stage IV 
endometriosis who was confirmed to have extensive endometriosis 
at laparoscopy. (1) sagittal gray-scale TVS image shows irregular 
thickening of the right USL associated 10 mm endometriosis 
nodule in proximal. (2) Also, a moderate thickening of left USL has 
been shown. c Bowel DIE in two women. (1) Sagittal gray-scale TVS 
image in a woman with severe dysmenorrhea shows a hypoechoic 
nodule involving the serosal layer in the lower rectum. (2) Transverse 
gray-scale TVS images in a woman with chronic pelvic pain and 
cramping, show a hypoechoic nodule in the rectosigmoid junction 
with severe adhesion to the posterior of the uterus fundus
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symptoms and a diagnosis of endometriosis based on 
ultrasound examination and laparoscopic confirmation. 
The definitive diagnosis of all patients during this period 
was confirmed by laparoscopy and pathological examina-
tion. The required information was extracted from the 
patient’s ultrasound examination report and question-
naires then included in the special forms designed for 
this purpose. The severity of pain was determined by 
Point Pain Numbered Scale 11 (NRS11) [12]. Patients 
filled out self-administered questionnairesand ranked 
their pain ranging from zero to ten. Exclusion crite-
ria included other causes of pelvic pain such as pelvic 
inflammatory disease (PID), pelvic varices, ovarian cysts 
except for endometrioma, gastrointestinal and urinary 
problems, and gynecological surgery history. Ultrasound 
examinations were done by Philips Affiniti 70 ultrasound 
machine with three models including C-10 3v, C5-1, and 
L12-3 examining vaginal probe (10-3 MHz), curve probe 
(5–1  MHz) and linear probe (12–3  MHz), respectively. 
All ultrasound examinations were performed by an expe-
rienced radiologist who was unaware of the type and 
severity of the patient’s pain. It wasdone based on the 
systematic protocol introduced by the International Deep 
Endometriosis Analysis (IDEA) Consensus Group [13]. 
Ultrasound examination includes the evaluation of uter-
ine and adnexa, the assessment of the sliding sign, dedi-
cated search for DIE, and the detection of sonographic 
soft markers such as localized tenderness [13]. The dis-
ease stage was scored based on the r-ASRM classification 
[14]. For this purpose, systematic ultrasound data with 
endometriosis protocol confirmed by laparoscopic data 
were used.
Results were statistically analyzed using the SPSS 24. 
To describe quantitative data, mean and standard devia-
tion and for qualitative data, frequency and percentage 
were used. Accordingly, Chi-square and Fisher’s statisti-
cal tests were used to investigate the association of any of 
the symptoms such as dysmenorrhea, dyspareunia, and 
pelvic pain with endometrioma, Douglas pouch stenosis, 
intestinal involvement, and stage of the disease.. Finally, 
to examine the relationship between each symptom and 
the stage of the disease, a logistic regression test for 
sequential data was used.
Results
A total of 296 patients underwent ultrasonography 
based on endometriosis protocol at the Department 
of Radiology between January 2018 and August 2020. 
Out of 296 patients, 142 cases were excluded as follows: 
patients with incomplete ultrasound report (0.67%), 
with amenorrhea (n = 5, 1.6%); with the previous resec-
tion of DIE (n = 7, 2.3%), with an insufficient descrip-
tion of the posterior DIE (n = 10, 3.3%), and patients 
who do not intend to participate in the study (n = 118, 
39.8%). Finally, 154 patients remained to be examined. 
The demographic characteristics and clinical data of 
patients are presented. The mean age of participants 
was 32.4 ± 6.2 years. The presence and severity of pain 
based on the disease stages (according to r-ASRM clas-
sification) are presented in Table  1. The severity of 
dysmenorrhea, dyspareunia, and chronic pelvic pain 
considering theextension of the disease are presented 
in Table  2. Typical ovarian endometrioma, uterosacral 
ligament, and bowel involvement with DIE is displayed 
in Fig. 1a–c, respectively.
Of the 154 women studied, 150 (48.7%) had dysmen-
orrhea, 75 (97.4%) had dyspareunia, and 75 (48.7%) had 
chronic pelvic pain.
The cumulative size of posterior DIE is (less than 
1  cm) significantly correlated with minimal sever-
ity of dyspareunia (p = 0.04) and chronic pelvic pain 
(p = 0.03). Patients with complete stenosis of Douglas 
pouch had higher dyspareunia than those with incom-
plete Douglas pouch stenosis. Further, the incidence of 
severe and very severe pain in patients with Douglas 
pouch stenosis is relatively higher than that in patients 
without stenosis.
Using logistic regression analysis, it can be concluded 
that only dyspareunia is related to the stage of the dis-
ease so that patients with dyspareunia are 5 times more 
at risk of a higher stage of the disease.













 Stage I 0 1 (8.3) 2 (16.7) 9 (75) 0.61
 Stage II 0 0 3 (30) 7 (70)
 Stage III 0 9 (15.8) 18 (31.6) 30 (52.6)
 Stage IV 4 (5.5) 7 (9.6) 22 (30.1) 40 (54.8)
Dyspareunia
 Stage I 5 (45.5) 0 4 (36.4) 2 (18.2) 0.48
 Stage II 4 (44.4) 0 3 (33.3) 2 (22.2)
 Stage III 21 (47.7) 8 (18.2) 7 (15.9) 8 (18.2)
 Stage IV 20 (34.5) 12 (20.7) 17 (29.3) 9 (15.5)
Chronic pelvic pain
 Stage I 7 (58.3) 0 2 (16.7) 3 (25) 0.05
 Stage II 5 (50) 0 5 (50) 0
 Stage III 35 (60.3) 9 (15.5) 10 (17.2) 4 (6.9)
 Stage IV 32 (44.7) 22 (30.6) 13 (18.1) 5 (6.9)
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 The cumulative size of DIE implants
  < 1 cm 22 0 2 (9.1) 9 (40.9) 11 (50)
  1–3 cm 47 1 (2.1) 4 (8.5) 19 (40.4) 23 (48.9)
  > 3 cm 41 2 (4.9) 4 (9.8) 11 (26.8) 24 (58.5)
 The cumulative surface of superficial peritoneal implants 0.48
  0 142 4 (2.8) 16 (11.3) 40 (28.2) 82 (57.7)
  < 3 cm 5 0 1 (20) 3 (60) 1 (20)
  > 3 cm 5 0 0 2 (40) 3 (60)
 Endometrioma 0.53
 None 28 0 2 (7.1) 5 (17.9) 21 (75)
 Unilateral 78 3 (3.8) 12 (15.4) 22 (28.2) 41 (52.6)
 Bilateral 51 1 (2) 3 (5.9) 18 (35.3) 29 (56.9)
 Cumulative size of endometriomas 0.31
  0 28 0 2 (7.1) 5 (17.9) 21 (75)
  ≤ 3 cm 26 2 (7.7) 5 (19.2) 6 (23.1) 13 (50)
  > 3 cm 100 2 (2) 10 (10) 34 (34) 54 (54)
 Size of the largest endometrioma 0.69
  0 26 0 2 (7.7) 5 (19.2) 19 (73.1)
  ≤ 3 cm 43 2 (4.7) 5 (11.6) 14 (32.6) 22 (51.2)
  > 3 cm 85 2 (2.4) 10 (11.8) 26 (30.6) 47 (55.3)
 Douglas obliteration 0.42
  Absent 21 0 3 (14.3) 7 (33.3) 11 (52.4)
  Partial 53 3 (5.7) 7 (13.2) 11 (20.8) 32 (60.4)
  Complete 75 1 (1.3) 7 (9.3) 27 (36) 40 (53.3)
 Cumulative size of posterior DIE 0.7
  < 1 cm 22 0 2 (9.1) 9 (40.9) 11 (50)
  1–3 cm 46 1 (2.2) 3 (6.5) 19 (41.3) 23 (50)
  > 3 cm 40 2 (5) 4 (10) 10 (25) 24 (60)
 Sub peritoneal extension 0.82
  Sub-peritoneal only 92 2 (2.2) 10 (10.9) 27 (29.3) 53 (57.6)
  Rectal 51 2 (3.9) 5 (9.8) 16 (31.4) 28 (54.9)
  Vaginal 1 0 0 1 (100) 0
  Both rectal and vaginal 2 0 0 0 2 (100)
Dyspareunia severity
 Cumulative size of DIE implants
  < 1 cm 16 10 (62.5) 3 (18.8) 1 (6.3) 2 (12.5) 0.05
  1–3 cm 36 13 (36.1) 4 (11.1) 9 (25) 10 (27.8)
  > 3 cm 37 13 (34.2) 9 (23.7) 13 (34.2) 2 (7.9)
 Cumulative surface of superficial peritoneal implants
  0 113 46 (40.7) 19 (16.8) 27 (23.9) 21 (18.6) 0.48
  < 3 cm 4 1 (25) 0 3 (75) 0
  > 3 cm 5 3 (60) 1 (20) 1 (20) 0
 Endometrioma
  None 26 11 (42.3) 2 (7.7) 9 (34.6) 4 (15.4) 0.14
  Unilateral 61 23 (37.7) 13 (21.3) 11 (18) 14 (23)
  Bilateral 40 18 (45) 7 (17.5) 12 (30) 3 (7.5)











 Cumulative size of endometriomas
  0 26 11 (42.3) 2 (7.7) 9 (34.6) 4 (15.4) 0.52
  ≤ 3 cm 22 10 (45.5) 3 (13.6) 7 (31.8) 2 (9.1)
  > 3 cm 76 29 (38.2) 16 (21.1) 16 (21.1) 15 (19.7)
 Size of the largest endometrioma
  0 24 10 (41.7) 1 (4.2) 9 (37.5) 4 (16.7) 0.30
  ≤ 3 cm 36 16 (44.4) 5 (13.9) 7 (19.4) 8 (22.2)
  > 3 cm 64 24 (37.5) 15 (23.4) 16 (25) 9 (14.1)
 Douglas obliteration
  Absent 16 7 (43.8) 2 (12.5) 5 (31.3) 2 (12.5) 0.06
  Partial 48 12 (25) 10 (20.8) 18 (37.5) 8 (16.7)
  Complete 56 29 (51.8) 8 (14.3) 8 (14.3) 11 (19.6)
 Cumulative size of posterior DIE
  < 1 cm 16 10 (62.5) 3 (18.8) 1 (6.3) 2 (12.5) 0.04
  1–3 cm 35 12 (34.3) 4 (11.4) 9 (25.7) 10 (28.6)
  > 3 cm 37 12 (32.4) 9 (24.3) 13 (35.1) 3 (8.1)
 Sub peritoneal extension
  Sub-peritoneal only 72 35 (48.6) 8 (11.1) 15 (20.8) 14 (19.4) 0.07
  Rectal 42 13 (31) 11 (26.2) 13 (31) 5 (11.9)
  Vaginal 1 0 0 0 1 (100)
  Both rectal and vaginal 2 1 (50) 0 1 (50) 0
Chronic pelvic pain severity
 The cumulative size of DIE implants
  < 1 cm 23 15 (65.2) 6 (26.1) 1 (4.3) 1 (4.3) 0.07
  1–3 cm 46 24 (52.2) 6 (13) 13 (28.3) 3 (6.5)
  > 3 cm 41 19 (46.3) 14 (34.1) 5 (12.2) 3 (7.3)
 The cumulative surface of superficial peritoneal implants
  0 142 74 (52.1) 27 (19) 30 (21.1) 11 (7.7) 0.26
  < 3 cm 5 2 (40) 3 (60) 0 0
  > 3 cm 5 3 (60) 1 (20) 0 1 (20)
 Endometrioma
  None 28 13 (46.6) 4 (14.3) 8 (28.6) 3 (10.7) 0.25
  Unilateral 79 44 (55.7) 15 (19) 13 (16.5) 7 (8.9)
  Bilateral 50 22 (44) 16 (32) 10 (20) 2 (4)
 The cumulative size of endometriomas
  0 28 13 (46.6) 4 (14.3) 8 (28.6) 3 (10.7) 0.68
  ≤ 3 cm 26 15 (57.7) 4 (15.4) 5 (19.2) 2 (7.7)
  > 3 cm 100 51 (51) 25 (25) 17 (17) 7 (7)
 Size of the largest endometrioma
  0 26 13 (50) 2 (7.7) 8 (30.8) 3 (11.5) 0.38
  ≤ 3 cm 42 21 (50) 10 (23.8) 7 (16.7) 4 (9.5)
  > 3 cm 86 45 (52.3) 21 (24.4) 15 (17.4) 5 (5.8)
 Douglas obliteration
  Absent 21 13 (61.9) 2 (9.5) 4 (19) 2 (9.5) 0.5
  Partial 52 22 (42.3) 15 (28.8) 10 (19.2) 5 (9.6)
  Complete 76 43 (56.6) 14 (18.4) 14 (18.4) 5 (6.6)
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Discussion
Endometriosis is one of the challenges for women with 
pelvic pain and infertility. Chronic pelvic pain affects 
about 15% of women of childbearing age and reduces 
their quality of life [15]. In the present study, the mean 
age of patients was 32.4 years, and the disease was highly 
severe in less than half of the cases, which is consistent 
with results of Khawaja et al. [16]. The infertility rate in 
women with endometriosis in the present study was 
37.3%, which is consistent with the study of Radhika et al. 
[17]. Bellelis et  al. [18] reported infertility rates as 31.5 
and 40%, respectively.
This study aimed to explore the relationship between 
the severity of endometriosis symptoms (dyspareunia, 
dysmenorrhea, and chronic pelvic pain) and the spread 
of the disease. The results show that only the severity of 
dyspareunia is related to the stage of endometriosis, and 
the odds ratio of endometriosis was 0.24 in the absence 
of dyspareunia. In previous studies, many attempts have 
been made to clarify the association of the type and loca-
tion of lesions and the spread of the disease with the 
severity and symptoms of the disease, which has had no 
consensus on results [19].
The growth of nerve fibers in ectopic implants is con-
sidered as the mechanism of severe pain in endometri-
osis [20–22]. According to Varecellini et  al.’s study [19], 
dysmenorrhea, as one of the most common symptoms of 
endometriosis, was associated with atypical and popu-
lar implants. Fedele et  al. [23] reported the association 
of dysmenorrhea with advanced stages of endometrio-
sis. Chapron et  al. [24], showed that dysmenorrhea was 
associated with the size and depth of the lesions. How-
ever, in other studies, there was no relationship between 
menstrual pain and endometriosis [25], which shows that 
other factors cause this pain, and merely examining the 
appearance of implants can reveal the true nature of the 
disease.
In the present study, there was no relationship 
between dysmenorrhea and chronic pelvic pain, and 
disease severity. The results of this study are incon-
sistent with those of Varcellini et al. [19], who found a 
significant association of disease severity and dysmen-
orrhea with chronic pelvic pain. Although their esti-
mated odds ratio for dysmenorrhea and chronic pelvic 
pain (1.33 and 1.01, respectively) was very close to 1 
and does not indicate any strong correlation. A slight 
change in the sample volume possibility causes the 
missing of the confidence interval.
Results of the present study suggested that there is a 
significant relationship between dyspareunia and pos-
terior DIE lesion, and has been strongly confirmed in 
other studies. Anatomically, the most stretched area 
during intercourse is the retro-cervical area [26], which 
indicates the organic nature of this pain. Anaf et  al. 
[27] showed a histological relationship between nerves 
and endometriotic foci in retro-cervical nodules [28]. 
Besides, Douglas stenosis was significantly associated 
with dyspareunia in the present study, which has been 
reported in almost all previous studies. Varcellini et al. 
reported a strong association between Douglas pouch 
lesions and dyspareunia [19].
Studies show that the association between ovar-
ian endometriosis and dysmenorrhea has conflicting 
results. Although endometrioma was common among 
the patients in the present study (83.4%), no signifi-
cant association was found between endometrioma 
and dysmenorrhea, which is consistent with the results 
of some researchers (Radhika et al. [17], Porpora et al. 
[29], Chapron et  al. [24], and Koninckx et  al. [30]). In 
contrast, Muzii et al. [31] and Fedele et al. [23] showed 
thatthe association between endometrioma and pel-
vic pain was significant, which is inconsistent with the 











 Cumulative size of posterior DIE
  < 1 cm 23 15 (65.2) 6 (26.1) 1 (4.3) 1 (4.3) 0.03
  1–3 cm 45 24 (53.3) 5 (11.1) 13 (28.9) 3 (6.7)
  > 3 cm 40 18 (45) 14 (35) 5 (12.5) 3 (7.5)
 Sub peritoneal extension
  Sub-peritoneal only 91 49 (53.3) 18 (19.6) 17 (18.5) 8 (8.7) 0.93
  Rectal 51 25 (49) 12 (23.5) 11 (21.6) 3 (5.9)
  Vaginal 1 1 (100) 0 0 0
  Both rectal and vaginal 2 1 (50) 1 (50) 0 0
a Represents the number and percentage of women with degree of severity of dysmenorrhea, dyspareunia, and chronic pelvic pain
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Conclusion
The results of the present study show that the severity 
of dyspareunia is related to the stage of endometrioma 
and the severity of Douglas pouch stenosis. The present 
study shows the correlation between chronic pelvic 
pain and r-ASRM score. Additional prospective studies 
are needed to validate the results of this study.
Limitations
Some aspects of this study that are affected by cultural 
considerations or moral codes includedthe frequency 
and details of sexual activity and symptoms like dys-
pareunia, which may cause biases in data collection.
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